- Home
- COLL vs MTAL Comparison
COLL vs MTAL Comparison
Compare COLL & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- MTAL
- Stock Information
- Founded
- COLL 2002
- MTAL 2021
- Country
- COLL United States
- MTAL Jersey
- Employees
- COLL N/A
- MTAL N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- MTAL Blank Checks
- Sector
- COLL Health Care
- MTAL Finance
- Exchange
- COLL Nasdaq
- MTAL Nasdaq
- Market Cap
- COLL 910.2M
- MTAL 830.2M
- IPO Year
- COLL 2015
- MTAL 2021
- Fundamental
- Price
- COLL $28.07
- MTAL $8.14
- Analyst Decision
- COLL Strong Buy
- MTAL Buy
- Analyst Count
- COLL 5
- MTAL 2
- Target Price
- COLL $43.60
- MTAL $14.75
- AVG Volume (30 Days)
- COLL 438.9K
- MTAL 442.2K
- Earning Date
- COLL 05-08-2025
- MTAL 01-01-0001
- Dividend Yield
- COLL N/A
- MTAL N/A
- EPS Growth
- COLL 43.56
- MTAL N/A
- EPS
- COLL 1.86
- MTAL N/A
- Revenue
- COLL $631,449,000.00
- MTAL $340,736,000.00
- Revenue This Year
- COLL $20.00
- MTAL $24.36
- Revenue Next Year
- COLL $3.93
- MTAL $16.52
- P/E Ratio
- COLL $15.63
- MTAL N/A
- Revenue Growth
- COLL 11.41
- MTAL 114.30
- 52 Week Low
- COLL $27.28
- MTAL $8.71
- 52 Week High
- COLL $42.29
- MTAL $15.26
- Technical
- Relative Strength Index (RSI)
- COLL 37.90
- MTAL 24.34
- Support Level
- COLL $29.01
- MTAL $10.15
- Resistance Level
- COLL $30.53
- MTAL $10.88
- Average True Range (ATR)
- COLL 0.82
- MTAL 0.40
- MACD
- COLL -0.10
- MTAL -0.22
- Stochastic Oscillator
- COLL 5.73
- MTAL 0.00
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.